Stockscreener 앱 받기
7.43
4.65%
0.33
전일 마감가:
$7.10
열려 있는:
$7.02
하루 거래량:
1.66M
Relative Volume:
2.26
시가총액:
$457.53M
수익:
$217.25M
순이익/손실:
$-50.92M
주가수익비율:
-7.43
EPS:
-1
순현금흐름:
$-100.85M
1주 성능:
-12.59%
1개월 성능:
-27.58%
6개월 성능:
-58.02%
1년 성능:
-66.23%
1일 변동 폭
$6.92
$8.08
1주일 범위
$6.92
$8.7996
52주 변동 폭
$6.92
$25.42
Prothena Corporation Plc Stock (PRTA) Company Profile
명칭
Prothena Corporation Plc
전화
011-353-1-236-2500
주소
77 SIR JOHN ROGERSON'S QUAY, BLOCK C, DUBLIN 2
PRTA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PRTA
Prothena Corporation Plc
|
7.43 | 457.53M | 217.25M | -50.92M | -100.85M | -1.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
424.99 | 128.84B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
527.78 | 65.38B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ARGX
Argen X Se Adr
|
549.65 | 39.67B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
251.15 | 33.82B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ONC
Beigene Ltd Adr
|
231.99 | 27.60B | 3.81B | -644.79M | -669.77M | -6.24 |
Prothena Corporation Plc Stock (PRTA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-12-20 | 개시 | Chardan Capital Markets | Buy |
| 2024-01-30 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2023-12-12 | 개시 | Deutsche Bank | Buy |
| 2023-04-24 | 개시 | SVB Securities | Outperform |
| 2023-01-27 | 개시 | Piper Sandler | Overweight |
| 2022-11-04 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-09-28 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2021-11-19 | 개시 | JMP Securities | Mkt Outperform |
| 2021-06-18 | 업그레이드 | BofA Securities | Underperform → Neutral |
| 2021-06-08 | 재확인 | Oppenheimer | Outperform |
| 2021-05-26 | 개시 | Citigroup | Buy |
| 2021-02-26 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2021-02-12 | 업그레이드 | Jefferies | Hold → Buy |
| 2021-02-02 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2020-12-07 | 개시 | H.C. Wainwright | Buy |
| 2020-07-09 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2019-11-19 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2018-05-21 | 다운그레이드 | Barclays | Equal Weight → Underweight |
| 2018-04-23 | 다운그레이드 | Jefferies | Buy → Hold |
| 2018-04-05 | 재확인 | Barclays | Overweight |
| 2017-11-20 | 다운그레이드 | Wedbush | Outperform → Neutral |
| 2017-09-29 | 재확인 | BTIG Research | Buy |
| 2017-09-15 | 개시 | RBC Capital Mkts | Outperform |
| 2017-08-17 | 개시 | Evercore ISI | Outperform |
| 2017-07-11 | 개시 | Jefferies | Buy |
| 2017-04-12 | 개시 | Cantor Fitzgerald | Overweight |
| 2017-04-12 | 개시 | Piper Jaffray | Overweight |
| 2017-03-02 | 개시 | Instinet | Buy |
| 2016-12-21 | 개시 | SunTrust | Buy |
| 2016-11-03 | 개시 | Deutsche Bank | Buy |
| 2016-08-04 | 재확인 | Barclays | Overweight |
| 2016-05-13 | 개시 | Barclays | Overweight |
| 2016-02-19 | 재확인 | Wedbush | Outperform |
| 2016-01-21 | 개시 | Credit Suisse | Outperform |
모두보기
Prothena Corporation Plc 주식(PRTA)의 최신 뉴스
JMP Securities Has Lowered Expectations for Prothena (NASDAQ:PRTA) Stock Price - Defense World
Prothena Co. plc (NASDAQ:PRTA) Shares Bought by Dimensional Fund Advisors LP - Defense World
Prothena Corp (PRTA) Sees Price Target Reduction by HC Wainwrigh - GuruFocus
Prothena (PRTA) Price Target Reduced by H.C. Wainwright | PRTA S - GuruFocus
Prothena Corp (PRTA) Sees Price Target Reduction by HC Wainwright & Co. | PRTA Stock News - GuruFocus
Prothena Q1 Earnings Miss Estimates, Focus on Key Readouts in 2025 - Yahoo Finance
Prothena (PRTA) Price Target Adjusted, Outlook Remains Positive - GuruFocus
Prothena Corp (PRTA) Sees Price Target Adjusted by JMP Securities | PRTA Stock News - GuruFocus
Prothena Corp (PRTA) Receives Steady "Buy" Rating from Chardan Capital | PRTA Stock News - GuruFocus
RBC Trims Price Target on Prothena to $18 From $20, Keeps Sector Perform, Speculative Risk - marketscreener.com
Prothena (PRTA) Price Target Reduced by H.C. Wainwright | PRTA Stock News - GuruFocus
Is Prothena Corporation plc (PRTA) the Low Risk High Reward Stock Set to Triple by 2030? - Yahoo Finance
Prothena stock price target cut to $78 by Citizens JMP - Investing.com
Beyond The Numbers: 7 Analysts Discuss Prothena Corp Stock - Benzinga
Top 3 Health Care Stocks That Are Preparing To Pump This Quarter - Benzinga
Prothena Co. plc (NASDAQ:PRTA) Receives $55.00 Consensus Price Target from Analysts - Defense World
10 Low Risk High Reward Stocks Set to Triple by 2030 - Insider Monkey
Prothena Reports First Quarter 2025 Financial Results and Business Highlights - BioSpace
Prothena (PRTA) Reports Q1 Loss, Misses Revenue Estimates - Yahoo Finance
Prothena (PRTA) Expects Key Clinical Milestones and Financial Outlook for 2025 | PRTA Stock News - GuruFocus
Prothena Corporation PLC reports results for the quarter ended March 31Earnings Summary - TradingView
Prothena: Q1 Earnings Snapshot - marketscreener.com
Prothena Corp PLC Q1 2025 Earnings: EPS of -$1.12 Misses Estimates, Revenue Falls Short at $2.8 Million - GuruFocus
U.S. Transthyretin Amyloidosis Treatment Market Set to Witness - openPR.com
Prothena Corporation PLC expected to post a loss of 97 cents a shareEarnings Preview - TradingView
Insiders Re-Evaluate Their US$2.75m Stock Purchase As Prothena Falls To US$458m - Yahoo
Barclays PLC Buys 10,116 Shares of Prothena Co. plc (NASDAQ:PRTA) - Defense World
Invesco Ltd. Purchases 1,632 Shares of Prothena Co. plc (NASDAQ:PRTA) - Defense World
Prothena Corporation plc (PRTA) Stock: Uncovering 52-Week Market Trends - investchronicle.com
Prothena Corporation plc (PRTA) did well last session? - uspostnews.com
Press Release Distribution & PR Platform - ACCESS Newswire
Prothena Co. plc (NASDAQ:PRTA) Shares Sold by Wells Fargo & Company MN - Defense World
Prothena to Report First Quarter 2025 Financial Results on May 8 - BioSpace
Post-Trade Analysis: Prothena Corporation plc (PRTA) Slides -5.06, Closing at 9.20 - DWinneX
Legal & General Group Plc Reduces Stock Holdings in Prothena Co. plc (NASDAQ:PRTA) - Defense World
Prothena outlines potential multi-billion dollar opportunity with birtamimab launch by 2026 - MSN
Analytical Lens: Exploring Prothena Corporation plc (PRTA)’s Financial Story Through Ratios - DWinneX
It would be worthwhile to take a closer look at Prothena Corporation plc (PRTA) - uspostnews.com
Mariner LLC Has $4.76 Million Stock Position in Prothena Co. plc (NASDAQ:PRTA) - The AM Reporter
19,687 Shares in Prothena Co. plc (NASDAQ:PRTA) Bought by Franklin Resources Inc. - Defense World
JPMorgan Chase & Co. Purchases 187,364 Shares of Prothena Co. plc (NASDAQ:PRTA) - Defense World
(PRTA) Technical Pivots with Risk Controls - news.stocktradersdaily.com
Vanguard Group Inc. Boosts Stake in Prothena Co. plc (NASDAQ:PRTA) - Defense World
Prothena Co. plc (NASDAQ:PRTA) Shares Bought by American Century Companies Inc. - Defense World
Norges Bank Invests $796,000 in Prothena Co. plc (NASDAQ:PRTA) - Defense World
Raymond James Financial Inc. Acquires New Stake in Prothena Co. plc (NASDAQ:PRTA) - Defense World
Corebridge Financial Inc. Sells 1,596 Shares of Prothena Co. plc (NASDAQ:PRTA) - Defense World
Prothena Co. plc (NASDAQ:PRTA) Given Average Rating of “Moderate Buy” by Brokerages - Defense World
KLP Kapitalforvaltning AS Purchases Shares of 12,900 Prothena Co. plc (NASDAQ:PRTA) - Defense World
Thrivent Financial for Lutherans Sells 8,889 Shares of Prothena Co. plc (NASDAQ:PRTA) - Defense World
Teacher Retirement System of Texas Purchases Shares of 10,434 Prothena Co. plc (NASDAQ:PRTA) - Defense World
Prothena Corporation Plc (PRTA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Prothena Corporation Plc 주식 (PRTA) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| EcoR1 Capital, LLC | 10% Owner |
May 06 '25 |
Sale |
7.64 |
1,984,053 |
15,164,712 |
5,304,596 |
| EcoR1 Capital, LLC | 10% Owner |
May 05 '25 |
Sale |
8.11 |
977,693 |
7,930,166 |
7,288,649 |
| SCULLY WILLIAM P | 10% Owner |
Jan 14 '25 |
Buy |
12.79 |
100,000 |
1,279,040 |
735,993 |
| SCULLY WILLIAM P | 10% Owner |
Dec 18 '24 |
Buy |
13.93 |
73,436 |
1,022,670 |
1,297,693 |
| SCULLY WILLIAM P | 10% Owner |
Dec 31 '24 |
Buy |
13.01 |
32,000 |
416,393 |
650,193 |
| SCULLY WILLIAM P | 10% Owner |
Dec 20 '24 |
Buy |
15.91 |
2,000 |
31,813 |
618,693 |
0.84%
0.15%
자본화:
|
볼륨(24시간):